Publisher
Springer Science and Business Media LLC
Reference31 articles.
1. World Health Organisation. Global Tuberculosis Report 2016; 2016. p. 214. Available from:
http://apps.who.int/iris/bitstream/10665/250441/1/9789241565394-eng.pdf?ua=1
. [cited 2017 Jul 20]
2. Gupta A, Wood R, Kaplan R, Bekker LG, Lawn SD. Prevalent and Incident Tuberculosis Are Independent Risk Factors for Mortality among Patients Accessing Antiretroviral Therapy in South Africa. Polis MA, editor. PLoS One. 2013;8:e55824 Available from:
http://dx.plos.org/10.1371/journal.pone.0055824
. [cited 2017 Jul 20].
3. Gupta RK, Lucas SB, Fielding KL, Lawn SD. Prevalence of tuberculosis in post-mortem studies of HIV-infected adults and children in resource-limited settings: a systematic review and meta-analysis. AIDS. 2015;29:1987–2002 Available from:
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4568896&tool=pmcentrez&rendertype=abstract
. [cited 2016 Apr 11].
4. World Health Organisation. Policy statement: automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF system. Geneva: World Health Organisation; 2011.
5. Boehme CC, Nicol MP, Nabeta P, Michael JS, Gotuzzo E, Tahirli R, et al. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet. 2011;377:1495–505 Available from:
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3085933&tool=pmcentrez&rendertype=abstract
. [cited 2012 Jul 13].
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献